Solasia Pharma KK (4597)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Solasia Pharma KK (4597) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014399
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Solasia Pharma KK (Solasia Pharma) formerly JapanBridge Inc is a healthcare service provider that provides patient access to Western oncology therapies. The company develops and commercializes oncology therapies and cancer supportive care products. Its products include transdermal system which delivers the anti-emetic and granisetron in the patient’s bloodstream without the need for injections and swallowing pills. Solasia Pharma also offers a mitochondrial-targeted agent used for the treatment of various hematologic and solid cancers. It also offers chemotherapy induced nausea and vomiting therapy for patients receiving emetogenic chemotherapy regimens. The company markets its products to Japan, China and Asian countries. Solasia Pharma is headquartered in Tokyo, Japan.

Solasia Pharma KK (4597) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Solasia Pharma KK, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Solasia Pharma KK, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Solasia Pharma KK, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Solasia Pharma KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Solasia Pharma KK, Medical Devices Deals, 2011 to YTD 2017 9
Solasia Pharma KK, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Solasia Pharma KK, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Solasia Pharma Enters into Licensing Agreement with PledPharma 11
Lee’s Pharma Enters into Licensing Agreement with Solasia Pharma 12
Meiji Seika Pharma Enters into Licensing Agreement with Solasia Pharma for Episil 13
Lee’s Pharma Enters into Licensing Agreement with Solasia Pharma for Sancuso 14
Solasia Pharma Enters into Licensing Agreement with Camurus for episil Oral Liquid 15
Solasia Pharma Enters into Licensing Agreement with Meiji Seika Pharma for Darinaparsin 16
Ziopharm Amends Licensing Agreement with Solasia Pharma for Darinaparsin 17
ZIOPHARM Oncology Enters Into Licensing Agreement With Solasia Pharma For Darinaparsin 19
Equity Offering 21
Solasia Pharma to Raise USD31.9 Million in IPO 21
Solasia Pharma KK – Key Competitors 22
Solasia Pharma KK – Key Employees 23
Solasia Pharma KK – Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Solasia Pharma KK, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Solasia Pharma KK, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Solasia Pharma KK, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Solasia Pharma KK, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Solasia Pharma KK, Deals By Therapy Area, 2011 to YTD 2017 8
Solasia Pharma KK, Medical Devices Deals, 2011 to YTD 2017 9
Solasia Pharma KK, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Solasia Pharma Enters into Licensing Agreement with PledPharma 11
Lee’s Pharma Enters into Licensing Agreement with Solasia Pharma 12
Meiji Seika Pharma Enters into Licensing Agreement with Solasia Pharma for Episil 13
Lee's Pharma Enters into Licensing Agreement with Solasia Pharma for Sancuso 14
Solasia Pharma Enters into Licensing Agreement with Camurus for episil Oral Liquid 15
Solasia Pharma Enters into Licensing Agreement with Meiji Seika Pharma for Darinaparsin 16
Ziopharm Amends Licensing Agreement with Solasia Pharma for Darinaparsin 17
ZIOPHARM Oncology Enters Into Licensing Agreement With Solasia Pharma For Darinaparsin 19
Solasia Pharma to Raise USD31.9 Million in IPO 21
Solasia Pharma KK, Key Competitors 22
Solasia Pharma KK, Key Employees 23

★海外企業調査レポート[Solasia Pharma KK (4597)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Peako Ltd (PKO):石油・ガス:M&Aディール及び事業提携情報
    Summary Peako Ltd (Peako), formerly Peak Oil & Gas Ltd, is an oil and gas, and mineral exploration company. The company carries out the business of acquisition, exploration, and development of oil, natural gas, petroleum, and uranium properties. Its projects include SC6C Cadlao and Sunday Creek proj …
  • Fiserv, Inc.:企業の戦略・SWOT・財務情報
    Fiserv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fiserv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Parkway Properties Inc:企業のM&A・事業提携・投資動向
    Parkway Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Parkway Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Berry Global Group Inc:戦略・SWOT・企業財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Power Machines:企業の戦略的SWOT分析
    Power Machines - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and special botanical drugs. It also offers drugs suc …
  • Rubis SCA (RUI):企業の財務・戦略的SWOT分析
    Rubis SCA (RUI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • CRH public limited company (CRG):企業の財務・戦略的SWOT分析
    CRH public limited company (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Wellcome Trust Sanger Institute-製薬・医療分野:企業M&A・提携分析
    Summary Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research …
  • Tejas Networks Ltd (TEJASNET):企業の財務・戦略的SWOT分析
    Tejas Networks Ltd (TEJASNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Southwest Gas Corporation (SWX):企業の財務・戦略的SWOT分析
    Southwest Gas Corporation (SWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Daewoo Shipbuilding & Marine Engineering Co Ltd:企業の戦略・SWOT・財務分析
    Daewoo Shipbuilding & Marine Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daewoo Shipbuilding & Marine Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Gold Fields Ltd:戦略・SWOT・企業財務分析
    Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report Summary Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Obton AS-エネルギー分野:企業M&A・提携分析
    Summary Obton A/S (Obton) is an investment company that specializes in management of assets within renewable energy. The company's investment process include screening process which inludes verification of prerequisites such as financial terms, amount of irradiation, power purchase agreement and fee …
  • Spark New Zealand Ltd:企業の戦略・SWOT・財務情報
    Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report Summary Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AusNet Services Ltd (AST)-エネルギー分野:企業M&A・提携分析
    Summary AusNet Services Ltd (AusNet) is a diversified energy network business entity that transmits and distributes power. It owns and manages electricity transmission network in Victoria; and delivers electricity to various customer connection points in eastern Victoria including Melbourne’s outer …
  • Havells India Ltd (HAVELLS):企業の財務・戦略的SWOT分析
    Havells India Ltd (HAVELLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SPAR Osterreichische Warenhandels AG:企業の戦略的SWOT分析
    SPAR Osterreichische Warenhandels AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • NovioSense BV:医療機器:M&Aディール及び事業提携情報
    Summary NovioSense BV (NovioSense) is a medical device company that develops a wireless technology platform for non-invasive monitoring of disease biomarkers. The company offers NovioSense, a glucose sensor to monitor glucose levels in the tear fluid and sends a wireless signal to a handheld unit or …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆